Scientific and Medical Equipment House Company (4014.SR)
SAR 51.1
(0.2%)
SAR 51.1
(0.2%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 68.65 Million SAR | 35.57% |
| 2022 | 50.67 Million SAR | -48.72% |
| 2021 | 98.81 Million SAR | 2.57% |
| 2020 | 96.33 Million SAR | 4.81% |
| 2019 | 91.91 Million SAR | 8.09% |
| 2018 | 85.03 Million SAR | 18.77% |
| 2017 | 71.59 Million SAR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 14.8 Million SAR | -4.49% |
| 2024 Q1 | 15.5 Million SAR | -56.16% |
| 2023 Q3 | 24.95 Million SAR | 201.87% |
| 2023 FY | 68.7 Million SAR | 35.57% |
| 2023 Q4 | 35.35 Million SAR | 41.72% |
| 2023 Q1 | 12.29 Million SAR | 167.81% |
| 2023 Q2 | 8.26 Million SAR | -32.78% |
| 2022 Q4 | -18.13 Million SAR | -213.78% |
| 2022 FY | 50.67 Million SAR | -48.72% |
| 2022 Q2 | 22.17 Million SAR | -9.37% |
| 2022 Q1 | 24.46 Million SAR | 9.85% |
| 2022 Q3 | 15.93 Million SAR | -28.12% |
| 2021 Q2 | 27.29 Million SAR | 31.45% |
| 2021 Q1 | 20.76 Million SAR | 6.73% |
| 2021 FY | 98.81 Million SAR | 2.57% |
| 2021 Q4 | 22.27 Million SAR | 15.92% |
| 2021 Q3 | 19.21 Million SAR | -29.61% |
| 2020 Q2 | 23.95 Million SAR | -0.0% |
| 2020 Q1 | 23.95 Million SAR | 0.0% |
| 2020 FY | 96.33 Million SAR | 4.81% |
| 2020 Q4 | 19.45 Million SAR | 0.0% |
| 2020 Q3 | 19.45 Million SAR | -18.79% |
| 2019 FY | 91.91 Million SAR | 8.09% |
| 2018 FY | 85.03 Million SAR | 18.77% |
| 2017 FY | 71.59 Million SAR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|